| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |